Costa Rica

Latin America

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Costa Rica is regulated by the CCSS (Caja Costarricense de Seguro Social). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

CCSS (Caja Costarricense de Seguro Social)

Regulatory Pathways (1)

Costa Rica MOH Named Patient Authorization 30 days

Costa Rica Ministry of Health named patient authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Costa Rica Named Patient Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Costa Rica

ISO Code	`CR`
Region	Latin America
Regulatory Authority	CCSS (Caja Costarricense de Seguro Social)
Pathways	1 documented
Drugs Available	0 documented